Selective inhibition of microRNA accessibility by RBM38 is required for p53 activity
| dc.contributor.author | Léveillé, Nicolas | |
| dc.contributor.author | Elkon, Ran | |
| dc.contributor.author | Davalos, Veronica | |
| dc.contributor.author | Manoharan, Vijayalaxmi | |
| dc.contributor.author | Hollingworth, Dave | |
| dc.contributor.author | Vrielink, Joachim Oude | |
| dc.contributor.author | Le Sage, Carlos | |
| dc.contributor.author | Melo, Carlos A. | |
| dc.contributor.author | Horlings, Hugo M. | |
| dc.contributor.author | Wesseling, Jelle | |
| dc.contributor.author | Ule, Jernej | |
| dc.contributor.author | Esteller, Manel | |
| dc.contributor.author | Ramos, Andres | |
| dc.contributor.author | Agami, Reuven | |
| dc.date.accessioned | 2018-09-03T11:00:57Z | |
| dc.date.available | 2018-09-03T11:00:57Z | |
| dc.date.issued | 2011-10-25 | |
| dc.date.updated | 2018-07-24T12:59:16Z | |
| dc.description.abstract | MicroRNAs (miRNAs) interact with 3'-untranslated regions of messenger RNAs to restrict expression of most protein-coding genes during normal development and cancer. RNA-binding proteins (RBPs) can control the biogenesis, stability and activity of miRNAs. Here we identify RBM38 in a genetic screen for RBPs whose expression controls miRNA access to target mRNAs. RBM38 is induced by p53 and its ability to modulate miRNA-mediated repression is required for proper p53 function. In contrast, RBM38 shows lower propensity to block the action of the p53-controlled miR-34a on SIRT1. Target selectivity is determined by the interaction of RBM38 with uridine-rich regions near miRNA target sequences. Furthermore, in large cohorts of human breast cancer, reduced RBM38 expression by promoter hypermethylation correlates with wild-type p53 status. Thus, our results indicate a novel layer of p53 gene regulation, which is required for its tumour suppressive function. | |
| dc.format.extent | 11 p. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.pmid | 22027593 | |
| dc.identifier.uri | https://hdl.handle.net/2445/124207 | |
| dc.language.iso | eng | |
| dc.publisher | Nature Publishing Group | |
| dc.relation.isformatof | Reproducció del document publicat a: http://dx.doi.org/10.1038/ncomms1519 | |
| dc.relation.ispartof | Nature Communications, 2011, vol. 2, num. 513 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/EC/FP7/201900/EU//MIREG | |
| dc.relation.uri | http://dx.doi.org/10.1038/ncomms1519 | |
| dc.rights | cc by-nc-nd (c) Léveillé et al., 2011 | |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/es/ | |
| dc.source | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) | |
| dc.subject.classification | RNA | |
| dc.subject.classification | Càncer de mama | |
| dc.subject.other | RNA | |
| dc.subject.other | Breast cancer | |
| dc.title | Selective inhibition of microRNA accessibility by RBM38 is required for p53 activity | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:eu-repo/semantics/publishedVersion |
Fitxers
Paquet original
1 - 1 de 1